Price target
68.270.000.00%
The 11 analysts offering 1 year price forecasts for RNA have a max estimate of — and a min estimate of —.
Analyst rating
Based on 11 analysts giving stock ratings to RNA in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
RNA EPS for the last quarter is −0.65 USD despite the estimation of −0.71 USD. In the next quarter EPS is expected to reach −0.79 USD. Track more of Avidity Biosciences, Inc. financials and stay on top of what is up with the company.
In the next quarter Avidity Biosciences, Inc. revenue is expected to reach 1.63 M USD. Check out Avidity Biosciences, Inc. revenue and earnings and make informed decisions.
According to analysts, RNA price target is 68.27 USD with a max estimate of 96.00 USD and a min estimate of 51.00 USD. Check if this forecast comes true in a year, meanwhile watch Avidity Biosciences, Inc. stock price chart and keep track of the current situation with RNA news and stock market news.
We've gathered opinions of 11 analysts rating RNA stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.